DaVita (DVA): financials, SEC filings and peers
DaVita (DVA) is a health care services company in the Health Care sector of the S&P 500, headquartered in Denver, Colorado.
It was founded in 1979 and joined the S&P 500 on July 31, 2008.
Its fiscal year ends in December, and its shares trade on the NYSE.
In its SEC filings it is classified as “Services-Misc Health & Allied Services, NEC”.
DaVita at a glance
- Revenue (12 months)
- $14.2B
- Revenue growth
- +6.4%
- Operating margin
- 15.0%
- Net income (12 months)
- $920M
- Free cash flow (12 months)
- $1.3B
- Cash
- $496M
- Debt
- $10.8B
- Diluted EPS (12 months)
- $13.51
Twelve months to September 30, 2026, from the 10-Q filed October 29, 2026.
Latest twelve months
Over the twelve months to September 30, 2026, DaVita reported revenue of $14.2 billion, about the same as a year earlier (+6.4%).
Its operating margin was 15.0%: for every $100 of sales, about $15 was left as operating profit.
Net income was $920 million (6.5% of revenue), 19.2% higher than a year earlier.
Operating cash flow was $1.9 billion and capital spending $577 million, leaving free cash flow of $1.3 billion (9.1% of revenue).
At the end of the period it held $496 million in cash and $10.8 billion in debt, a net debt position of $10.3 billion.
The diluted share count fell 11.2% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $11.6 billion in fiscal 2020 to $13.6 billion in fiscal 2025, about 3.4% a year.
- Revenue has grown for 3 fiscal years in a row.
- Operating margin has been steady, around 15.0%.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $11.6B | $11.6B | $12.1B | $12.8B | $13.6B |
| Revenue growth | 0.6% | -0.1% | 4.6% | 5.6% | 6.5% |
| Operating margin | 15.5% | 11.5% | 13.2% | 16.3% | 15.0% |
| Net income | $978M | $560M | $692M | $936M | $747M |
| Free cash flow | $1.3B | $961M | $1.5B | $1.5B | $1.3B |
| Diluted EPS | $8.90 | $5.85 | $7.42 | $10.73 | $9.84 |
Fiscal years as reported in DaVita’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed October 29, 2026 — quarterly report
- 8-K filed October 29, 2026 — Earnings results
- 10-Q filed August 4, 2026 — quarterly report
- 8-K filed August 4, 2026 — Earnings results
- 8-K filed June 8, 2026 — Material agreement; New debt obligation
- 10-Q filed May 5, 2026 — quarterly report
- 8-K filed May 5, 2026 — Earnings results
- 10-K filed February 11, 2026 — annual report
Companies like DaVita
Other S&P 500 companies in Health Care Services:
- CICignaBloomfield, Connecticut
- CVSCVS HealthWoonsocket, Rhode Island
- DGXQuest DiagnosticsSecaucus, New Jersey
- LHLabcorpBurlington, North Carolina
More from Health Care
Questions about DaVita
Is DaVita's revenue growing?
Yes. Revenue for the twelve months to September 30, 2026 was $14.2 billion, up 6.4% from a year earlier, according to its SEC filings.
Is DaVita profitable?
Yes. It earned $920 million in net income over the twelve months to September 30, 2026, a net margin of 6.5%.
Does DaVita have more cash or more debt?
At September 30, 2026 it had $496 million in cash and $10.8 billion in debt, so more debt than cash.
When did DaVita last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on October 29, 2026.
Which companies are similar to DaVita?
In the S&P 500, DaVita is grouped in Health Care Services within the Health Care sector. Cigna (CI), CVS Health (CVS), Quest Diagnostics (DGX), Labcorp (LH) are in the same group.
Understand the numbers
Source: DaVita’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.